.png)
ULTIMATE DEEP DIVE IN MAJOR RECENT CLINICAL TRIALS
CardioVascular, CardioRenal and Cardiometabolic medicine is the most evidence-based medicine.
Every year brings a series of landmark, game changing trials.
Beyond the initial 10-15 minutes "Late Breaking Clinical Trials " presentations at international conferences, sometimes simultaneously to the publications of the main results, and with only limited discussion on social media, CVCT is the only global meeting where hours are spent dissecting individual trials results, in the context of adjacent trials, among the most diverse and authoritative stakeholders, including investigators, statisticians, methodologists, major journal editors, regulators, clinicians, industry R&D experts, payers, and patients.
THE LARGEST GLOBAL GATHERING OF CLINICAL TRIALS KEY STAKEHOLDERS!
CVCT assembles the most diverse group of stakeholders, because the implementation of the results of clinical trials includes understanding
- trial rationale,
- design issues,
- trial conduct
- operational issues,
- statistical interpretation
- clinical meaning,
- approvability by major regulatory agencies,
- valuation by payers and Health Technology Agencies,
- translation into practice guidelines, and
- implementation in real life by physicians
ONLY THINK-TANK MULTISTAKEHOLDER BRAINSTORMING, NON-COMPETITIVE CASE STUDIES
Rather than lecturing, most scientific sessions’ time is dedicated to experts think tank debates. Healthy controversy and civil discourse are welcome.
The aim of CVCT is to improve:
- trial designs,
- statistical methods,
- trial participants selection, including diversity,
- endpoint definition,
- regulatory agencies guidance,
- trials execution,
- trial results interpretation reporting and publication,
- grading of evidence,
- updating guidelines,
- economic valuation and coverage of therapy,
- implementation in clinical practice,
- patient participants engagement and
- training of young future trialists
Controlled growth
THE GLOBAL CVCT FORUM HAS GROWN STEADILY AND SLOWLY, WITH CONTROLLED GROWTH AS TO STAND TO ITS REPUTATION OF A “BOUTIQUE MEETING”.
